A model of 131I-huA33 pharmacodynamics in patients with colorectal carcinoma.

被引：0
|
作者：
Papenfuss, AT
Chong, G
Schleyer, PJ
Chappell, B
O'Keefe, GJ
Scott, AM
机构：
[1] Austin & Repatriat Med Ctr, Melbourne, Vic, Australia
[2] Ludwig Inst Canc Therapy, Melbourne, Vic, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
861
引用
收藏
页码：210P / 210P
页数：1
相关论文
共 50 条
  • [31] Acute Hematologic Consequences of High-Dose I-131 Therapy for Aggressive Thyroid Carcinoma.
    Lagrew, J. E.
    Bush, H. M.
    Ain, K. B.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [32] The usefulness of therapeutic 131I SPECT-CT in Differentiated Thyroid Carcinoma. A preliminary study
    Mhiri, A.
    Slim, I.
    Meddeb, I.
    El Ajmi, W.
    Elbez, I.
    Ben Slimene, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S285 - S285
  • [33] Evaluation of the impact of 131I-SPECT and integrated low-dose CT in the neck area on the management of patients with thyroid carcinoma.
    Meddeb, I.
    Mhiri, A.
    Slim, I.
    Elbez, I.
    El Ajmi, W.
    Ben Sellem, D.
    Zaabar, L.
    Letaief, B.
    Ghezaiel, M.
    Ben Slimene, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S285 - S286
  • [34] Practical dosimetry of 131I in patients with thyroid carcinoma
    Sisson, JC
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) : 101 - 105
  • [35] Do scanning doses of I-131 stun thyroid remnants? A comparison of 37 vs 111 MBq before first I-131 ablative therapy in patients with differentiated thyroid carcinoma.
    Muratet, JP
    Giraud, P
    Daver, A
    Minier, JF
    Larra, F
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 163 - 163
  • [36] Repeated bone marrow analyses for cytokeratin positive cells in patients with colorectal carcinoma.
    Liljefors, M.
    Frodin, J-E.
    Porwit, A.
    Ragnhammar, P.
    Mellstedt, H.
    Shetye, J.
    ANNALS OF ONCOLOGY, 2007, 18 : 49 - 49
  • [37] Evaluation of preoperative geriatric assessment of elderly patients with colorectal carcinoma. A retrospective study
    Indrakusuma, R.
    Dunker, M. S.
    Peetoom, J. J.
    Schreurs, W. H.
    EJSO, 2015, 41 (01): : 21 - 27
  • [38] Outcomes after noncurative locoregional treatment in patients with unresectable metastatic colorectal carcinoma.
    Yang, Qiong
    Liao, Fangxin
    Liu, Shousheng
    Jiang, Chang
    He, Wen-zhuo
    Xia, Liang-ping
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [39] Liver transplantation (Ltx) in patients with nonresectable liver metastases from colorectal carcinoma.
    Dueland, Svein
    Hagness, Morten
    Line, Pal-Dag
    Scholz, Tim
    Jorgensen, P.
    Fosby, Bjarte
    Mathisen, Ostein
    Gladhaug, Ivar
    Foss, Aksel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [40] The therapeutic efficacy of 131I labeled A33 antibody combined with external beam in the treatment of colorectal carcinoma xenografts in nude mice.
    Ruan, S
    O'Donoghue, J
    Finn, R
    Larson, SM
    Humm, JL
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 69P - 69P
12345